Moderate alcohol consumption is associated with impaired insulin secretion and fasting glucose in non-obese non-diabetic men.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
May 2021
Historique:
revised: 28 07 2020
received: 15 01 2020
accepted: 03 09 2020
pubmed: 11 9 2020
medline: 10 11 2021
entrez: 10 9 2020
Statut: ppublish

Résumé

A low insulin secretion capacity has been implicated in the high prevalence of non-obese diabetes in East Asians. As alcohol consumption alters insulin and glucose metabolism, we tested the hypothesis that alcohol consumption contributes to impaired insulin secretion and glucose intolerance in lean/normal-weight non-diabetic Japanese men. This cross-sectional study was undertaken among the residents of Shika town, Japan, between 2011 and 2017. A total of 402 non-diabetic men, including participants with normal fasting plasma glucose (FPG) and impaired FPG (FPG 5.6-6.9 mmol/L), and aged ≥40 years, were examined. FPG, the homeostasis model assessment of insulin secretion capacity (HOMA-B) and alcohol consumption were evaluated and compared between the body mass index (BMI) <25 and BMI ≥25 groups. HOMA-B levels were lower in the BMI <25 group than in the BMI ≥25 group. Alcohol consumption correlated with a low HOMA-B level regardless of BMI, and, thus, the HOMA-B levels of alcohol drinkers were significantly lower in the BMI <25 group. A multivariable logistic regression analysis showed that alcohol consumption, even light-to-moderate consumption (1-25 g/day), was associated with significantly low levels of HOMA-B and impaired FPG in the BMI <25 group. Among participants with impaired FPG, a low level of HOMA-B was observed in alcohol drinkers, but not in non-drinkers. In contrast, light-to-moderate alcohol consumption was not related to HOMA-B or FPG in the BMI ≥25-group. Alcohol consumption, even a small amount, might contribute to reductions in HOMA-B levels and impaired FPG in lean/normal-weight Japanese men.

Identifiants

pubmed: 32910554
doi: 10.1111/jdi.13402
pmc: PMC8089003
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

869-876

Informations de copyright

© 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

Nutr J. 2010 Mar 22;9:14
pubmed: 20307313
Metab Syndr Relat Disord. 2005;3(1):45-50
pubmed: 18370709
J Diabetes Investig. 2010 Oct 19;1(5):191-5
pubmed: 24843431
Diabetes Care. 2004 Jan;27(1):184-9
pubmed: 14693987
Ann Clin Biochem. 2017 Nov;54(6):631-635
pubmed: 27705886
Alcohol Clin Exp Res. 2001 Jun;25(6 Suppl):19S-23S
pubmed: 11410736
Diabetes Res Clin Pract. 2018 Jan;135:11-17
pubmed: 29111281
Toxicol Appl Pharmacol. 2016 Oct 1;308:11-19
pubmed: 27538709
Nagoya J Med Sci. 2016 May;78(2):183-93
pubmed: 27303105
Diabetes Care. 1999 Sep;22(9):1432-7
pubmed: 10480505
J Cardiovasc Med (Hagerstown). 2008 May;9(5):450-60
pubmed: 18403996
Diabetes Care. 2005 Mar;28(3):719-25
pubmed: 15735217
Diabetes Care. 2015 Apr;38(4):723-32
pubmed: 25805864
Diabetes. 1981 Sep;30(9):705-9
pubmed: 7021270
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Diabetologia. 1985 Aug;28(8):574-8
pubmed: 3902546
J Epidemiol. 2012;22(2):151-9
pubmed: 22343326
Diabetes Care. 2009 Nov;32(11):2123-32
pubmed: 19875607
Alcohol Clin Exp Res. 2018 Dec;42(12):2326-2336
pubmed: 30207601
J Diabetes Investig. 2017 Jan;8(1):56-68
pubmed: 27181845
Diabetologia. 2012 Dec;55(12):3228-37
pubmed: 22935962
Am J Clin Nutr. 2012 Jul;96(1):44-9
pubmed: 22648716
Nature. 2003 May 29;423(6939):550-5
pubmed: 12754525
Lancet. 2006 Nov 11;368(9548):1681-8
pubmed: 17098087
Am J Clin Nutr. 2009 Sep;90(3):595-601
pubmed: 19640960
Asia Pac J Clin Nutr. 2008;17(4):545-51
pubmed: 19114388
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174
Diabet Med. 2005 Mar;22(3):323-31
pubmed: 15717882
Sci Rep. 2015 Dec 21;5:18422
pubmed: 26687910
Int J Obes (Lond). 2009 Feb;33(2):197-203
pubmed: 19125162
PLoS One. 2011;6(6):e19930
pubmed: 21731609

Auteurs

Sakae Miyagi (S)

Department of Environmental and Preventive Medicine, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.
Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan.

Toshinari Takamura (T)

Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.

Thao Thi Thu Nguyen (TTT)

Department of Environmental and Preventive Medicine, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

Hiromasa Tsujiguchi (H)

Department of Environmental and Preventive Medicine, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

Akinori Hara (A)

Department of Environmental and Preventive Medicine, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

Haruki Nakamura (H)

Department of Environmental and Preventive Medicine, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

Keita Suzuki (K)

Department of Environmental and Preventive Medicine, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

Atsushi Tajima (A)

Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

Takayuki Kannon (T)

Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

Tadashi Toyama (T)

Innovative Clinical Research Center, Kanazawa University, Kanazawa, Japan.

Yasuhiro Kambayashi (Y)

Department of Public Health, Faculty of Veterinary, Okayama University of Science, Okayama, Japan.

Hiroyuki Nakamura (H)

Department of Environmental and Preventive Medicine, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH